Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Retatrutide for Sale > Over 99% purity Retatrutide Weight Loss Direct factory shipment peptide
Over 99% purity Retatrutide Weight Loss Direct factory shipment peptide buy - large image1
Over 99% purity Retatrutide Weight Loss Direct factory shipment peptide buy - image1
Over 99% purity Retatrutide Weight Loss Direct factory shipment peptide buy - image2
Over 99% purity Retatrutide Weight Loss Direct factory shipment peptide buy - image3
Over 99% purity Retatrutide Weight Loss Direct factory shipment peptide buy - image4
Over 99% purity Retatrutide Weight Loss Direct factory shipment peptide buy - image5
Over 99% purity Retatrutide Weight Loss Direct factory shipment peptide buy - image6

Over 99% purity Retatrutide Weight Loss Direct factory shipment peptide

7519 Inquiries

Unit Price:

$61-66/G FOB

Get Latest Price
CAS No.:

2381089-83-2

Content:

99%

Port:

shenzhen

Brand:

WEIYA

Packaging:

5mg/10mg/15mg/20mg/30mg/40mg/50mg/60mg/100mg*10vials/box

Sample Available:

Yes

Price valid (until):

2026-11-29

Company Type:
Trader
Location:
China
Payment Terms:
100% TT in advance
Average Lead Time:
2 days
Qualification:
Main Products:

Tirzepatide,Retatrutide,Semaglutide,Melanotan,peptide,Selank

  • Product Details

  • Seller Information

  • Inquiry History

  • Description
    Product Description
    Shop Over 99% purity Retatrutide Weight Loss Direct factory shipment peptide-Detailed Image 1
    Retatrutide
    Triple agonist peptide | Activates GLP‑1/GIP/GCGR pathways | Suppresses appetite, regulates blood glucose and supports weight loss
    Specification
    Shop Over 99% purity Retatrutide Weight Loss Direct factory shipment peptide-Detailed Image 2
    Multiple strengths available
    Multiple strengths are available: 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg, 100mg .
    Each vial contains 10g, 10 vials per box. 
    Minimum order: 1 box.
    Packing & Delivery
    Shop Over 99% purity Retatrutide Weight Loss Direct factory shipment peptide-Detailed Image 3
    Secure Packaging, Prompt Delivery
    We offer multiple shipping options, with both China domestic warehouse and 3 warehouses in the US, plus warehouses in Australia, Europe and Canada.

    · Specialized line shipping from China: ①.around 2 weeks
                                                                   ②.FedEx: 5–7 days delivery.
    · Shipment from local warehouse: ①approx. 5 days
                                                           ②.Next-day delivery: receive the product the very next day.

    Our packaging is secure and well-sealed. We guarantee a prompt reply within 24 hours, shipment within 48 hours after order placement, full logistics tracking and one-on-one dedicated service, to ensure the products reach you safely and intact.
    Shop Over 99% purity Retatrutide Weight Loss Direct factory shipment peptide-Detailed Image 4
    Shop Over 99% purity Retatrutide Weight Loss Direct factory shipment peptide-Detailed Image 5
    Certifications
    Shop Over 99% purity Retatrutide Weight Loss Direct factory shipment peptide-Detailed Image 6
    Purity over 99%, supports third-party verification
    Shop Over 99% purity Retatrutide Weight Loss Direct factory shipment peptide-Detailed Image 7
    Shop Over 99% purity Retatrutide Weight Loss Direct factory shipment peptide-Detailed Image 8
    After Sales Service
    Shop Over 99% purity Retatrutide Weight Loss Direct factory shipment peptide-Detailed Image 9
    Pre-sales: Multiple preferential policies are available for bulk orders, with customized discounts offered.
      In-sales: We provide real-time updates on shipment status. If parcels encounter customs detention or compliance issues, reshipment or refund options are available to ease your worries. 
    After-sales: We offer continuous technical guidance for product application together with long-term after-sales protection, so you can sell with confidence.
    Company Profile
    Shop Over 99% purity Retatrutide Weight Loss Direct factory shipment peptide-Detailed Image 10
     Weifang Weiya Trading Co., Ltd.established in 2014 ,is a globally recognized benchmark provider of one-stop CRO/CDMO services specialized in peptides.
    With 12 years of dedicated expertise in peptide manufacturing, we stand at the forefront of the industry and rank among China’s premier peptide manufacturers. We focus on peptide R&D, production and custom research services. Our products cover cosmetics, pharmaceuticals and scientific research fields, supplying peptide materials ranging from milligram to kilogram scales for global clients.
    We operate a GMP factory equipped with cutting-edge precision instruments for production, purification, testing, lyophilization and efficacy evaluation, including HPLC, LC-MS, GC, elemental analyzers and large-scale semi-preparative DAC-HPLC systems. We deliver high-quality peptides along with professional test reports such as purity analysis and mass spectrometry identification.
    Supported by an experienced R&D and production team, alongside a responsive sales team, we provide premium-quality products and thoughtful, dedicated service to every client.
    We have 3 warehouses in the US, plus warehouses in Australia, Europe and Canada.
    Shop Over 99% purity Retatrutide Weight Loss Direct factory shipment peptide-Detailed Image 11
    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
    Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    0

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Categories:

    Polypeptide

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Tirzepatide,Retatrutide,Semaglutide,Melanotan,peptide,Selank

    Location:

    Room 701, Unit 3, Building 7, Fanrong Zunfu, No.22 Mizhou East Road, Mizhou Subdistrict, Zhucheng City, Weifang City, Shandong Province, P.R.China

    Payment Terms:

    100% TT in advance

    Average lead Time:

    2 days

    Total Annual Revenue:

    $50 million-$100 million

    Total Employees:

    501-1000

    Year of Establishment:

    2026

    Company Certificates
    • Weifang Weiya Trading Co., Ltd.CAG CAG
    • Weifang Weiya Trading Co., Ltd.TR60 TR60
    • Weifang Weiya Trading Co., Ltd.TR10 TR10
    • Weifang Weiya Trading Co., Ltd.TR30 TR30
    • Weifang Weiya Trading Co., Ltd.KPV GHK KPV GHK
    • Weifang Weiya Trading Co., Ltd.RT20 RT20
    • Weifang Weiya Trading Co., Ltd.MOTS MOTS
    • Weifang Weiya Trading Co., Ltd.RT10 RT10
  • Inquiry History
    7519 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide

    4 MT Nov 2, 2026
    United Kingdom

    Retatrutide

    1 KG Nov 1, 2026
    United Kingdom

    Retatrutide

    10 MT Nov 1, 2026
    United Kingdom

    Retatrutide

    300 MG Oct 31, 2026
    Canada

    Retatrutide

    20 MG Oct 31, 2026
    South Korea

    Retatrutide

    1 G Oct 31, 2026
    South Africa

    Retatrutide

    5 MT Oct 31, 2026
    United States

    Retatrutide

    100 MT Oct 31, 2026
    Poland

    Retatrutide

    1 BOU Oct 30, 2026
    United States

    Retatrutide

    10 PCS Oct 30, 2026
    Paraguay

    Retatrutide

    1000 PCS Oct 30, 2026
    Nigeria

    Retatrutide

    30 G Oct 30, 2026
    United Kingdom

    retatrutide

    300 MG Oct 30, 2026
    United States

    Retatrutide

    10 G Oct 30, 2026
    Germany

    Retatrutide

    1 G Oct 30, 2026
    New Zealand

    retatrutide

    10 MG Oct 30, 2026
    Thailand

    retatrutide

    10 MG Oct 30, 2026
    United Kingdom

    Retatrutide

    500 G Oct 30, 2026
    Spain

    Retatrutide

    100 G Oct 30, 2026
    Brazil

    Retatrutide

    10  Oct 29, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.